Rapid Nutrition Announces Swiss Fund Investment

November 28, 2019

LONDON UK - Rapid Nutrition PLC, (RAP:SW, OTCQB:RPNRF) (“Company”), a natural healthcare company focused on the research, development and production of a range of life science products, today announced it has completed a non-brokered placement of €240,000 led by Swiss Asset Manager, Alternative Gestion S.A. The placement (Convertible Instrument) consists of units at market price, each includes warrants at a 50% premium to market price.

 

The Conversion will increase the current share capital to a total number of voting rights 36'374'674, if fully exercised pursuant to the entry in the commercial register. The proceeds shall be used to fund the Company’s working capital and corporate strategy.

 

The new shares will be allotted subject only to admission to listing of the new shares on SIX Swiss Exchange. Such listing is expected to take place in due course.

 

Rapid Nutrition CEO, Simon St. Ledger stated, “We are pleased to attract institutional interest under favourable terms that will position the Company for continued growth heading into the first quarter of 2020. Further, we believe securing financing without discounting our equity speaks to the positive sentiment building in the institutional investor community, as well as our ongoing commitment to building long-term shareholder value.”  

 

About Rapid Nutrition

Rapid Nutrition is a natural healthcare company focused on the research, development and production of a range of life science products. The company was established based on its successful and proven weight loss supplement range which is exported worldwide and now offers consumers a growing range of health and well-being solutions to meet existing and emerging societal health concerns, as well as a providing number of wider services to the life sciences industry. For more information, please visit http://rnplc.com 

 

 

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

 

Disclosure Requirement:

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

 

 

Investor Relations Contact:

ir@mplc.com

Please reload

Featured Posts